Ingevity Corp
NGVTNYSEMaterials · Chemicals & Allied Products · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $1.17B | $1.20B | $1.22B | $1.67B | $1.39B | $1.22B |
| Operating income | $418.7M | $425.9M | $423.2M | $452.6M | $422.2M | $397.9M |
| Net income | −$167.1M | −$430.3M | −$5.4M | $211.6M | $118.1M | $181.4M |
| Total assets | $1.65B | $2.02B | $2.62B | $2.74B | $2.47B | $2.33B |
| Total liabilities | $1.62B | $1.83B | $1.99B | $2.04B | $1.80B | $1.69B |
| Equity | $29.7M | $195.2M | $631.4M | $698.3M | $673.8M | $642.1M |
| EPS (diluted) | $-4.61 | $-11.85 | $-0.15 | $5.50 | $2.95 | $4.37 |
| Shares out. | 36.4M | 36.2M | 37.2M | 39.0M | 40.5M | 41.8M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- 35.9%
- Net margin
- −14.3%
- Return on equity
- −562.6%
- Return on assets
- −10.1%
- Return on capital (ROCE)
- 32.0%
- Liabilities / assets
- 98.2%
- Debt / equity
- 54.59×
- Book value / share
- $0.82
- Revenue growth (YoY)
- −2.7%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- 2.97safe
- Accruals / assets
- −30.2%clean
- Piotroski F-Score
- 5/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 3 warning● 4 good- Reported a net loss
- Revenue declined year-over-year
- High leverage (liabilities > 70% of assets)
- Operating margin is positive
- Positive operating cash flow
- Clean earnings (low accruals)
- Altman Z″ in the safe zone
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Wellington Management Group LlpPassive (13G)May 15, 2026
- Vanguard Capital Management LlcPassive (13G)Apr 30, 2026
- Vanguard Portfolio Management LlcPassive (13G)Apr 29, 2026
- Vanguard Group IncPassive (13G)Mar 27, 2026
- Victory Capital Management IncPassive (13G)Oct 24, 2025
- Blackrock, Inc.Passive (13G)Apr 30, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 1.0M | 3.7 | -7.7% |
| Apr 30, 2026 | 1.1M | 5.3 | -3.0% |
| Apr 15, 2026 | 1.2M | 4.9 | -7.8% |
| Mar 31, 2026 | 1.2M | 3.2 | -2.8% |
| Mar 13, 2026 | 1.3M | 3.2 | -1.4% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Results of operationsMay 6, 2026
- Director / officer change · Shareholder voteMay 4, 2026
- Regulation FD disclosureApr 15, 2026
- Entered a material agreement · New financial obligationMar 30, 2026
- Results of operations · Regulation FD disclosureFeb 25, 2026
- Director / officer changeFeb 23, 2026
- Entered a material agreement · Completed an acquisition or disposition · Regulation FD disclosureJan 5, 2026
- Director / officer change · Regulation FD disclosureDec 8, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.